Roche has entered into a global exclusive licensing agreement with Rona Therapeutics valued at up to $1.16 billion, acquiring rights to the latter's investigational RNAi weight-loss drug candidate ...

Lallemand cast the spotlight on metabolic health at Vitafoods Asia, while underscoring the importance of working with local ...

Here are the facts Watch how it moves - this $150,000 robot feels almost too human 14 minutes, 3 news outlets: Trump’s new ...